Structural Biology – Products

Nicoya acquires Applied Photophysics, boosting biopharma capabilities with advanced analytical tools for protein-based drug discovery.

Sino Biological, with 15+ years of experience, has developed a proprietary mammalian transient expression platform using HEK293 and CHO cells.

Creative Peptides has enhanced its peptide library construction and screening services, incorporating advanced technologies like high-throughput screening, phage, and mRNA display to speed up drug discovery.

A new study highlights IsoPSA’s ability to identify low-risk prostate cancer patients who can avoid unnecessary interventions. The test also helps monitor high-risk patients more closely.

Nuclera has enhanced its eProtein Discovery™ system with a new membrane protein workflow, offering rapid expression, purification, and stabilization of membrane proteins.

Thermo Fisher Scientific has introduced the Thermo Scientific™ Krios™ 5 Cryo-TEM. This next-generation, atomic-resolution platform leverages enhanced optics and AI-enabled automation to study molecular structures.

AMSBIO announce a new range of Synthetic Nanodiscs that enable preparation of multi-pass transmembrane proteins in their active form, revolutionizing the future of membrane protein research and drug development.

Asynt report that the Cresswell Group, led by Dr Alexander J. Cresswell at the University of Bath (UK), have demonstrated the synthesis of novel spirocyclic tetrahydonaphthyridines (THNs) expanding the chemical space of these important scaffolds.

Discover how cutting-edge methodologies capture transient interactions with precision, providing a deeper understanding of complex binding dependencies.

Oxford Nanopore Technologies, announced a new collaboration with UK Biobank to create the world’s first comprehensive, large-scale epigenetic dataset.